444 related articles for article (PubMed ID: 25376920)
1. Stem cell therapies for systemic sclerosis.
Cipriani P; Ruscitti P; Giacomelli R
Br J Haematol; 2015 Feb; 168(3):328-37. PubMed ID: 25376920
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
Burt RK; Milanetti F
Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic stem cell transplantation for autoimmune diseases: nonmyeloablative conditioning regimens.
Oyama Y; Traynor AE; Barr W; Burt RK
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S81-3. PubMed ID: 12931250
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic HSCT for autoimmune diseases: conventional conditioning regimens.
Nash RA
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S77-80. PubMed ID: 12931249
[TBL] [Abstract][Full Text] [Related]
5. The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders.
Rebeiro P; Moore J
Intern Med J; 2016 Jan; 46(1):17-28. PubMed ID: 26524106
[TBL] [Abstract][Full Text] [Related]
6. Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective.
Hough RE; Snowden JA; Wulffraat NM
Br J Haematol; 2005 Feb; 128(4):432-59. PubMed ID: 15686452
[TBL] [Abstract][Full Text] [Related]
7. Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis.
van Laar JM; Naraghi K; Tyndall A
Rheumatology (Oxford); 2015 Dec; 54(12):2126-33. PubMed ID: 25953700
[TBL] [Abstract][Full Text] [Related]
8. [Autologous stem cell transplantation in systemic sclerosis].
Henes JC; Wirths S; Kötter I
Z Rheumatol; 2016 Oct; 75(8):762-769. PubMed ID: 27510996
[TBL] [Abstract][Full Text] [Related]
9. Autologous stem cell transplantation for systemic sclerosis.
Farge D; Nash R; Laar JM
Autoimmunity; 2008 Dec; 41(8):616-24. PubMed ID: 18958754
[TBL] [Abstract][Full Text] [Related]
10. Haematopoietic stem cell transplants: principles and indications.
Balassa K; Danby R; Rocha V
Br J Hosp Med (Lond); 2019 Jan; 80(1):33-39. PubMed ID: 30592675
[TBL] [Abstract][Full Text] [Related]
11. Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells.
Rosen O; Thiel A; Massenkeil G; Hiepe F; Häupl T; Radtke H; Burmester GR; Gromnica-Ihle E; Radbruch A; Arnold R
Arthritis Res; 2000; 2(4):327-36. PubMed ID: 11056673
[TBL] [Abstract][Full Text] [Related]
12. Changing winds in refractory autoimmune disease in children: clearing the road for tolerance with cellular therapies.
Swart JF; Lindemans CA; van Royen A; Boelens JJ; Prakken BJ; Wulffraat N
Curr Opin Rheumatol; 2012 May; 24(3):267-73. PubMed ID: 22418744
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D
Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
[TBL] [Abstract][Full Text] [Related]
14. [Stem cell treatment of autoimmune disease].
Daikeler T; Tyndall A
Dtsch Med Wochenschr; 2011 Aug; 136(33):1684-6. PubMed ID: 21833894
[TBL] [Abstract][Full Text] [Related]
15. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
[TBL] [Abstract][Full Text] [Related]
16. [High-dose chemotherapy followed by hematopoietic stem cell transplantation as therapy for systemic rheumatic autoimmune diseases].
van den Hoogen FH; Schattenberg AV; Breedveld FC; Fibbe WE; van de Putte LB
Ned Tijdschr Geneeskd; 1997 Oct; 141(43):2061-5. PubMed ID: 9550764
[TBL] [Abstract][Full Text] [Related]
17. [Hematopoietic stem cell transplantation in autoimmune diseases in rheumatology practice].
Kozák T; Becvár R; Havrdová E; Pitha J; Gregora E; Pytlík R; Maaloufová J; Kobylka P; Vodvárková S
Cas Lek Cesk; 2000 Jun; 139(11):329-33. PubMed ID: 10953411
[TBL] [Abstract][Full Text] [Related]
18. Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis.
Saccardi R; Tyndall A; Coghlan G; Denton C; Edan G; Emdin M; Farge D; Fassas A; Finke J; Furst D; Lassus M; Mancardi G; Miniati I; Mini E; Pagliai F; Passweg J; Pignone A; van Laar JM; Bocelli-Tyndall C; Matucci-Cerinic M
Bone Marrow Transplant; 2004 Nov; 34(10):877-81. PubMed ID: 15517007
[TBL] [Abstract][Full Text] [Related]
19. Haematopoietic stem cell transplantation in systemic sclerosis: Challenges and perspectives.
Di Benedetto P; Ruscitti P; Cipriani P; Giacomelli R
Autoimmun Rev; 2020 Nov; 19(11):102662. PubMed ID: 32942028
[TBL] [Abstract][Full Text] [Related]
20. Haematopoietic stem cell transplantation in autoimmune diseases: From basic science to clinical practice.
Kelsey PJ; Oliveira MC; Badoglio M; Sharrack B; Farge D; Snowden JA
Curr Res Transl Med; 2016; 64(2):71-82. PubMed ID: 27316390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
